Literature DB >> 17603562

Functional inhibition of PI3K by the betaGBP molecule suppresses Ras-MAPK signalling to block cell proliferation.

V Wells1, J Downward, L Mallucci.   

Abstract

The mechanisms of signal transduction from cell surface receptors to the interior of the cell are fundamental to the understanding of the role that positive and negative growth factors play in cell physiology and in human diseases. Here, we show that a functional link between phosphatidylinositol-3-OH kinase (PI3K) and Ras is suppressed by the beta-galactoside binding protein (betaGBP) molecule, a cytokine and a negative cell-cycle regulator. Ras-mitogen-activated protein kinase (MAPK) signalling is blocked by betaGBP owing to its ability to inhibit the p110 catalytic subunit of PI3K, whose basal activity is required for Ras activation. Functional inhibition of p110 by betaGBP results in downregulation of PI3K activity, suppression of Ras-GTP loading, consequent loss of MAPK activation and block of cell proliferation. This study sheds light on the molecular mechanisms whereby betaGBP can control cell proliferation and, by extension, may potentially control tumorigenesis by controlling PI3K.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603562     DOI: 10.1038/sj.onc.1210580

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.

Authors:  Arya Biragyn; Dan L Longo
Journal:  Semin Cancer Biol       Date:  2012-01-12       Impact factor: 15.707

2.  Killing of Kras-mutant colon cancer cells via Rac-independent actin remodeling by the βGBP cytokine, a physiological PI3K inhibitor therapeutically effective in vivo.

Authors:  Livio Mallucci; Dong-yun Shi; Derek Davies; Peter Jordan; Alastair Nicol; Lavinia Lotti; Renato Mariani-Costantini; Fabio Verginelli; Valerie Wells; Daniel Zicha
Journal:  Mol Cancer Ther       Date:  2012-07-02       Impact factor: 6.261

3.  EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation.

Authors:  Bo Li; Marc A Antonyak; Joseph E Druso; Le Cheng; Alexander Yu Nikitin; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 4.  PI 3-kinase and cancer: changing accents.

Authors:  Peter K Vogt; Marco Gymnopoulos; Jonathan R Hart
Journal:  Curr Opin Genet Dev       Date:  2009-02       Impact factor: 5.578

5.  Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.

Authors:  Mathieu Gigoux; Jijun Shang; Youngshil Pak; Minghong Xu; Jongseon Choe; Tak W Mak; Woong-Kyung Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

6.  Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

Authors:  Arkaitz Carracedo; Li Ma; Julie Teruya-Feldstein; Federico Rojo; Leonardo Salmena; Andrea Alimonti; Ainara Egia; Atsuo T Sasaki; George Thomas; Sara C Kozma; Antonella Papa; Caterina Nardella; Lewis C Cantley; Jose Baselga; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

7.  Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation.

Authors:  Dolgor Baatar; Purevdorj B Olkhanud; Valerie Wells; Fred E Indig; Livio Mallucci; Arya Biragyn
Journal:  Brain Behav Immun       Date:  2009-06-09       Impact factor: 7.217

8.  Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia.

Authors:  E J Gallagher; Y Fierz; A Vijayakumar; N Haddad; S Yakar; D LeRoith
Journal:  Oncogene       Date:  2011-10-31       Impact factor: 9.867

9.  Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.

Authors:  Zuoyun Wang; Yan Feng; Nabeel Bardeesy; Nabeel Bardessy; Kwok-Kin Wong; Xin-Yuan Liu; Hongbin Ji
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

10.  Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.

Authors:  Valerie Wells; Livio Mallucci
Journal:  Breast Cancer Res       Date:  2009-01-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.